Pre-Eclampsia Control

Home - liquid

Pre-Eclampsia Control

The Pre-eclampsia Control is intended for use with in vitro diagnostic assays for the quantitative determination of placental growth factor (PlGF) and soluble fms‑like tyrosine kinase‑1 (sFlt-1) in human serum and plasma.
The Pre-eclampsia Control is assayed with target values and is suitable for use on various immunoassay analysers. The Pre-eclampsia Control is for use by trained laboratory professionals and can be used in determining the precision of testing systems and in identifying sources of variation.

Features & Benefits

  • – Liquid frozen for user convenience
  • – Human based serum ensuring a commutable sample matrix
  • – 30 days open vial stability when stored at 2ºC to 8ºC keeping waste and costs to a minimum
  • – True third party control providing an unbiased assessment of performance
  • – Assayed target values provided
DescriptionSizeAnalytesCat NoContact Us
Pre-eclampsia Control Level 1 3 x 2 x 2 ml2PE10527
Pre-eclampsia Control Level 23 x 2 x 2 ml2PE10528
Pre-eclampsia Control Level 33 x 2 x 2 ml2PE10529

 

Therapeutic Drug Quality Control

Analytes

  • – sFlt-1
  • – PIGF

Active Vitamin B12 Quality Control

The Randox Acusera Active Vitamin B12 Control is designed to deliver a cost-effective, high quality solution for use in the quantitative determination of Active Vitamin B12 in human serum and plasma.

The human material based Active B12 Controls are assayed with target values provided and are suitable for use on various analysers.

Features & Benefits

  • Liquid frozen for user convenience
  • Human based serum ensuring a commutable sample matrix
  • True Third Party control providing unbiased assessment of performance
  • An impressive open vial stability of 30 days at 2° to 8°C helping to keep waste to a minimum
DescriptionSizeAnalytesCat No
Active Vitamin B12 Control Level 13 x 2 ml1VB10524
Active Vitamin B12 Control Level 23 x 2 ml1VB10525
Therapeutic Drug Quality Control

Analytes

  • Active Vitamin B12 (Holotranscobalamin/HoloTC)

Bone Markers (Serum) Control

The Lyophilised Serum Bone Marker Control is intended for use with in vitro diagnostic assays for the quantitative determination of Procollagen Type 1 N-Terminal Propeptide (P1NP), N-MID Osteocalcin (OC) and Bone Alkaline Phosphatase (B-ALP) in serum samples.

This Lyophilised Serum Bone Marker Control is assayed with target values and is suitable for use on automated analysers.

Features & Benefits

  • – Lyophilised for enhanced stability
  • – True third party control providing an unbiased assessment of performance
  • – Three clinically relevant levels available
  • – Human based serum providing a matrix similar to the patient sample
  • – 1 year shelf life from date of manufacture allowing for long term QC monitoring and a decrease in new lot validation studies
  • – 14- day reconstituted open vial stability applies for PINP and B-ALP helping to keep waste to a minimum, 1-day reconstituted stability for N-MID Osteocalcin
DescriptionSizeAnalytesCat NoContact Us
Bone Makers (Serum) Control Level 1 6 x 2ml3SBM10574
Bone Makers (Serum) Control Level 26 x 2ml3SBM10587
Bone Makers (Serum) Control Level 36 x 2ml3SBM10588

 

Therapeutic Drug Quality Control

Analytes

  • – PINP
  • – N-MID Osteocalcin
  • – Bone-ALP

*No claims are made regarding values and stability.


Xanthochromia Quality Control

The Randox Acusera Xanthochromia Control is designed to deliver a cost-effective, true third party solution for use in monitoring the performance of Bilirubin and Oxyhaemoglobin in Cerebrospinal Fluid (CSF) using a spectrophotometer.

Aqueous based with components of human origin, the Xanthochromia Controls are unassayed and are suitable for use with various UV spectrophotometers.

Supplied in a liquid frozen format, this control should be treated in the same manner as a patient sample.

Features & Benefits

  • Liquid frozen format for convenience and reduced handling errors
  • Human Based Material
  • True Third Party control providing unbiased assessment of performance
  • An Open Vial stability of 2 days at 2° to 8°C. Stable for 11 weeks when stored unopened at -18° to -24°C helping to keep waste to a minimum.
DescriptionSizeAnalytesCat NoContact Us
Xanthochromia Positive Control6 x 4 ml2XN10505
Xanthochromia Negative Control6 x 4 ml2XN10502
Therapeutic Drug Quality Control

Analytes

  • Billirubin
  • Oxyhaemoglobin

*No claims are made regarding values and stability.


Neonatal Bilirubin External Quality Assessment

The RIQAS Neonatal Bilirubin EQA programme has been designed to assess the performance of total and direct bilirubin assays with levels tailored to neonatal bilirubin testing.

  • Lyophilised for enhanced stability
  • Monthly reporting
  • Human based serum
  • Submit results and view reports online via RIQAS.net
  • Rapid turnaround of reports allows for any necessary corrective actions to be taken with minimal disruption to laboratory output

Not accredited to ISO/IEC 17043

Cat NoKit SizeFrequencyCycle StartParameters
RQ91912 x (6x3ml)MonthlyJuly2

Parameter

  • Direct Bilirubin
  • Total Bilirubin

Please note, product availability may vary country to country.


sTfR Quality Control

Therapeutic Drug Quality Control

Providing a true third party solution for the measurement of Soluble Transferrin Receptor (sTfR), the Acusera sTfR Control  will deliver an unbiased, independent assessment of analytical performance.

Designed for use with sTfR assays, this handy single analyte control saves money on wasted material.

Features & Benefits

  • Lyophilised control
  • Human based material
  • Assayed target values available
  • Stable to expiry date at 2°C to 8°C
  • Reconstituted stability of 30 days at 2°C to 8°C
DescriptionSizeAnalytesCat No
sTfR Control (Bi-level)3 x 2 x 1 ml1TF10162
sTfR Calibrator6 x 1 ml1TF10161

Analytes

  • Soluble Transferrin Receptor (sTfR)

Related Products


Complete QC Solutions for Results you can Trust

Randox is one of the largest manufacturers of true third party quality control solutions.  With over 35 years’ experience delivering reliable, high quality products designed to effectively challenge instrument performance you can be confident in the accuracy of patient test results, whilst reducing time and costs. With more than 390 analytes available across the Acusera range and a wide range of formats providing flexibility & choice, we have a solution to suit you.

Our diverse range of multi-analyte, third party controls offer industry leading opportunities for consolidation, ultimately delivering cost savings, reduced preparation time and increased efficiency all without compromising on quality. Manufactured using the highest quality raw materials, lot to lot consistency and unrivalled commutability is guaranteed, ensuring performance mirrors that of the patient sample and costly shifts in QC results are reduced.

  • Benefits

    acusera-consolidation

    Consolidation
    Specialising in consolidation, the Acusera range of multi-analyte controls is designed to reduce the number of individual controls required to cover your test menu, ultimately reducing costs, preparation time and storage space.

    acusera-commutability

    Commutability
    All Acusera controls are designed to react to the test system in the same manner as the patient sample, helping to meet ISO 15189:2012 requirements whilst reducing inconvenient and costly shifts in QC results when reagent batch is changed.

    Clinically-relevant-decision-levels

    Clinically Relevant Levels
    The presence of analytes at key decision levels not only helps to ensure accurate instrument performance but maximises laboratory efficiency by eliminating the need for additional low/high level controls at extra expense.

    acusera-reduce-waste

    Reduced Waste
    The unrivalled working stability of the Acusera control range helps to keep waste and costs to a minimum.

    acusera-flexible-options

    Flexibility
    With an extensive range of assayed/unassayed, liquid/lyophilised and single/multi-analyte controls, the Acusera portfolio has a solution to suit all laboratory preferences.

    acusera-third-party

    True Third Party Controls
    Manufactured independently, the Acusera range delivers unbiased performance assessment with any instrument or method, helping to meet ISO 15189:2012 requirements whilst simultaneously eliminating the need for multiple instrument dedicated controls.

Did you know?

Our controls are used in over 50,000 labs, hospitals and universities across the world.

Choose below to find a control that suits you.

Interlaboratory Data Management

Complementing our Internal Quality Control range is Acusera 24•7, a powerful data management tool designed to help even the most demanding laboratories manage their daily QC activities. Delivering unique access to real-time peer group statistics, a variety of fully interactive charts and automatic calculation of performance metrics such as Measurement Uncertainty, Acusera 24•7 will speed up data review and troubleshooting.

Learn More

Acusera Third Party Controls

Download Acusera Brochure

Contact Us


Product Spotlight: Liquid Lipid Control

product spotlight - liquid lipid control

Cardiovascular disease (CVD) is a general term for conditions affecting the heart or blood vessels. It is usually associated with a build-up of fatty deposits inside the arteries and increased risk of blood clots. It can be associated with damage to arteries in organs such as the brain, heart, kidney and eyes. Some types of CVD include coronary heart disease, strokes and aortic disease. Some of the main causes of CVD are smoking, high cholesterol, diabetes and high blood pressure (NHS, 2016).

These diseases can be extremely dangerous and lead to permanent damage or even death, therefore, it is vitally important for laboratories to be confident in their analyser’s ability to accurately diagnose and monitor the risk of these diseases.

Randox Liquid Lipid Control

The Randox Acusera Liquid Lipid quality control includes assayed target values and ranges for 8 analytes covering the complete lipid profile. With a 30 day open vial stability the Acusera Liquid Lipid control will reduce waste, whilst remaining easy and convenient to use. Three distinct levels are available covering low risk, borderline risk, and high risk concentrations of HDL and LDL cholesterol, ensuring the clinically relevant decision levels are tested, eliminating the need to purchase additional high and low level controls. Containing no Sodium Azide, which can interfere with direct clearance methods for  detecting HDL and LDL cholesterol, ensuring ultimate accuracy and confidence in results.

Key Features & Benefits

  • Liquid for ease of use
  • 100% human serum
  • Assayed target values provided
  • True third party control
  • Stable to expiry date at -20°C to -80°
  • Open vial stability of 30 days at 2°C to 8°C

Analytes

Apolipoprotein A  |  Apolipoprotein B  |  Cholesterol (HDL)  |  Cholesterol (LDL)
Cholesterol (Total)  |  C-Reactive Protein (CRP)  |  Lipoprotein (a)  |  Triglycerides

Featured Analytes

HDL Cholesterol

High-Density Lipoproteins (HDL) are one of the major classes of plasma lipoproteins. HDL is often referred to as ‘good cholesterol’ because it transports cholesterol from the tissues of the liver for removal from the body. High levels of HDL can indicate a lower risk of developing heart disease.

Apolipoprotein A-1

Apolipoprotein A-1 is one of the main protein forms found in High Density Lipoproteins (HDL). The chief role of Apolipoprotein A-1 is in the activation of lecithin cholesterol acyltransferase (LCAT) and the capture and removal of free cholesterol from extra hepatic tissue. Studies have shown that there is an inverse relationship between Apolipoprotein A-1 and coronary artery disease (CAD).

Related Products

Acusera Lipid Control

RIQAS Lipid EQA

Continue Reading

Download some of our related brochures below and broaden your understanding.

Product Spotlight Archive

Don’t forget to visit our Product Spotlight Archive and see spotlights from past months

References

NHS. (2016). Heart attack. nhs.uk. Retrieved 15 February 2018, from https://www.nhs.uk/conditions/heart-attack/

National Institute for Health and Care Excellence. (2014). Myocardial infarction (acute) Early rule out using high-sensitivity troponin testsNice.org.uk. Retrieved 15 February 2018, from https://www.nice.org.uk/guidance/dg15/chapter/3-clinical-need-and-practice


Product Spotlight: RIQAS CO-Oximetry EQA

Product Spotlight - RIQAS CO-Oximetry EQA Programme

RIQAS CO-Oximetry EQA

The RIQAS CO-Oximetry EQA Programme is a comprehensive programme suitable for monitoring the performance of 7 CO-Oximetry parameters. All samples are supplied in a liquid ready-to-use format ideal for both clinical and point-of-care testing (POCT).

Background

CO-Oximetry is a methodology that measures the levels of the oxygen-carrying protein haemoglobin, which is the chief component of red blood cells. CO-Oximetry is a useful tool in that it helps determine the levels of various forms of haemoglobin.

Key Benefits & Features

  • Liquid ready-to-use
  • Monthly reporting
  • Submit results and view reports online via RIQAS.Net
  • Suitable for POCT

Liquid ready-to-use

The liquid stable formulation requires no preparation making the samples extremely easy and convenient to use.

Consolidation

Covering 7 CO-Oximetry parameters, the RIQAS CO-Oximetry programme offers a streamlined approach to your EQA, allowing you to test your whole CO-Oximetry menu.

RIQAS

RIQAS is the largest international External Quality Assessment (EQA)/ Proficiency Testing (PT) scheme, there are currently more than 45,000 participants in 133 countries. World renowned for reducing the number of individual programmes required by even the most demanding laboratories.

Analytes

  • Carboxyhaemoglobin (COHb / HbCO)
  • Methaemoglobin (MetHb)
  • Oxygen Content (O₂CT)
  • Oxygen Saturation (sO / Vol O)
  • Oxyhaemoglobin (OHb / HbO)
  • Total Haemoglobin (tHb)
  • Reduced / Deoxyhaemoglobin (RHb / HHb)

Related Products

RIQAS Blood Gas EQA

Suitable for monitoring the performance of 10 blood gas parameters.

  • Accredited to ISO/IEC 17043
  • Liquid ready-to-use
  • Aqueous material
  • Monthly reporting
  • Submit results and view reports online via RIQAS.Net
  • Suitable for POCT

Download some of our related brochures below and broaden your understanding.

Product Spotlight Archive

Don’t forget to visit our Product Spotlight Archive and see spotlights from past months


References

Chatburn, R. (2014). To co-ox or not to co-oxAcutecaretesting.org. Retrieved 19 February 2018, from https://acutecaretesting.org/en/articles/to-coox-or-not-to-coox


Product Spotlight: Liquid Urinalysis Control

Product Spotlight - Jan - Liquid Urinalysis Quality Control

Liquid Urinalysis Quality Control

The Randox Acusera Urinalysis Quality Control is designed primarily to ensure accurate test system performance however offer the laboratory additional benefits that will help them to meet regulatory requirements whilst also reducing costs and time.

Background

It is estimated that 1 in 2 people will be affected by a urological condition at some point in their lifetime. Conditions and diseases related to kidneys, bladder and prostate, among others, are commonplace and can be devastating for millions of men, women and children across the globe.

Urological conditions can be common, such as urinary tract infections, or they can be much more serious, for example, prostate or testicular cancer.

Urinalysis is used as a screening or diagnostic tool because it can detect kidney and metabolic disorders. Often, substances such as glucose or protein will appear in the urine before a patient is aware that they have a problem. In some conditions, urinalysis also provides an easy and economical test to track patient progress, for example, if you want to know if a condition is improving.

Key Benefits & Features

  • Liquid ready-to-use
  • 100% human urine
  • Assayed ranges provided for 13 parameters
  • Suitable for use in POC testing
  • Stable to expiry date at 2°C – 8°C
  • Open vial stability of 30 days at 2°C – 25°C (20 immersions for UC5033/5034)

Consolidation

As a leading provider of multi-analyte, third party controls, Randox helps busy laboratories significantly reduce the number of controls needed to cover their test menu. The Randox Liquid Urinalysis Control combines multiple analytes into a single control reduces cost, preparation time, and required storage space without sacrificing quality. Analytes at key decision levels will ensure test system performance across the clinical range. It can also be used in monitoring the performance of both automated and manual methods of urine test strip analysis.

Liquid Stable

Samples are conveniently supplied ready-to-use requiring no preparation as such they can save valuable laboratory time. The Acusera Liquid Urinalysis Control can be used for POCT as well as laboratory based testing.

True third party quality control

The Acusera Liquid Urinalysis Quality Control is a true third party control designed to provide an unbiased assessment of performance with a range of instruments and methods, helping your laboratory meet the ISO 15189 requirements.

“the use of third party control materials should be considered,
either instead of, or in addition to, any control materials
supplied by the reagent or instrument manufacturer”.

Analytes

  • Albumin
  • Bilirubin
  • Blood
  • Creatinine
  • Glucose
  • hCG
  • Ketones
  • Leukocytes
  • Nitrate
  • pH
  • Protein
  • Specific Gravity
  • Urobilinogen

Complete QC solution

The combining of the Acusera Liquid Urinalysis Quality Control, RIQAS Urinalysis EQA programme, and our Acusera 24•7 software will provide a complete QC solution for laboratories of all sizes.

Download some of our related brochures below and broaden your understanding.

Product Spotlight Archive

Don’t forget to visit our Product Spotlight Archive and see spotlights from past months


Request a meeting
×
Make an Enquiry - RX series
×
Make an Enquiry - Reagents
×
Kit Insert Request - Reagents
  • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
×
Kit Insert Request - Reagents
  • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
×
Make an Enquiry - Reagents
×
Make an Enquiry - Quality Control